Medicaid Managed Care Reduces Rx Costs Despite Lower Rebates – Report
Executive Summary
Medicaid managed care organizations reduce pharmaceutical costs by 10% to 15% despite a significant disadvantage in ingredient costs compared to the traditional fee-for-service Medicaid program, a study by The Lewin Group and the Association for Health Center Affiliated Health Plans says
You may also be interested in...
Medicare Rx Hinges On Senate Finance Cmte.; White House Delays Details
The prospects for a Medicare drug benefit in 2003 are likely to hinge on the ability of the Senate Finance Committee to find a bipartisan consensus over the next several months
CMS Wants Bigger Medicaid Rebates, Elimination Of “Best Price”
The Bush Administration is proposing to eliminate the "best price" component of the Medicaid rebate system - and require a deeper mandatory discount
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011